Read the latest positive news, breakthroughs, and inspiring stories about healthcare costs, curated daily by BrightWire.
Billionaire Mark Cuban's Cost Plus Drugs is now manufacturing custom-made genetic medicines for individual rare disease patients, potentially slashing costs for life-saving treatments. After five years making generic drugs affordable, Cuban's Dallas factory has started producing personalized DNA-based therapies.
Brett Wilson beat cancer twice before age two and again later in life. Now at 53, she's helping families fight the hidden costs of cancer through her Pittsburgh nonprofit.
America's hospital finance chiefs are confronting an uncomfortable truth: the industry they built around medical billing is making healthcare unaffordable. A major conference just spotlighted how simplifying payments could save $200 billion annually.
New research shows that cutting doses of top cancer drugs like Keytruda could save $30 billion worldwide while working just as effectively. The finding could expand treatment access by 50 to 60% for patients who desperately need it.
%3Amax_bytes(150000)%3Astrip_icc()%3Afocal(749x0%3A751x2)%2FBert-Coffen-040726-1-9afa671e3f814bb59e02abd31b1b6c8a.jpg)
Herbert "Bert" Coffen survived lung cancer and served his country, but now he's back to work at 85 delivering meals to cover mounting medical costs. His community rallied with a GoFundMe to help the veteran and his wife finally rest.
%2Ffile%2Fdailymaverick%2Fwp-content%2Fuploads%2F2025%2F06%2Fpic-5-2.jpg)
Financial adviser Kenny Meiring offers families a roadmap for managing a loved one's finances when dementia arrives. His practical advice helps families balance dignity, care costs, and complex property decisions.
A 27-year-old Ohio nurse pays $15 for lab work in Bali instead of hundreds at home. Her story shows how medical tourism is helping Americans escape skyrocketing healthcare costs.
A new University of Pennsylvania study reveals telemedicine appointments cost five times less than in-person visits for common conditions, with patients needing fewer follow-ups. This isn't just about convenience anymore—it's about making healthcare more affordable and accessible for everyone.
Medicare just negotiated lower prices on 15 essential medications including cancer treatments and arthritis drugs, potentially saving patients and taxpayers billions. The new prices take effect in 2028, building on previous negotiations that would have saved $8.5 billion in 2024 alone.